XstalBio tackles challenging biologic formulations (required dosing too frequent, controlled release of API required, competitors hold blocking formulation patents, better adjuvant needed for target antigens, etc… ).
XstalBio tackles challenging biologic formulations (required dosing too frequent, controlled release of API required, competitors hold blocking formulation patents, better adjuvant needed for target antigens, etc… ).
HyTest is a finnish biotech company offering innovative solutions for assay development and research applications, and providing high-quality immunological reagents mainly in the cardiac markers area, but also in infectious, neuroscience and autoimmune disease reagents.
HyTest – antibody development for cardiac markers